Abbott Developing Novel Continuous Glucose-Ketone Monitoring System
Abbott is developing a new biowearable that will continuously monitor glucose and ketone levels in one sensor.
Read MorePosted by Andy Lundin | Jun 6, 2022 | Diabetes & Metabolic Diseases |
Abbott is developing a new biowearable that will continuously monitor glucose and ketone levels in one sensor.
Read MorePosted by Andy Lundin | Jun 3, 2022 | Diabetes & Metabolic Diseases |
Blood-based tests can be useful for initial diagnosis of liver disorders. Imaging methods are more accurate in assessing disorders severity.
Read MorePosted by Andy Lundin | May 31, 2022 | Kidney Disease |
Researchers established the inherited condition, TULP3-related ciliopathy, which causes kidney and liver failure in children and adults.
Read MorePosted by Andy Lundin | May 27, 2022 | Diabetes & Metabolic Diseases, Prenatal Testing |
Researchers may have identified an effective way of detecting gestational diabetes mellitus (GDM) earlier in pregnancy.
Read MorePosted by Andy Lundin | May 24, 2022 | Diabetes & Metabolic Diseases |
The American Liver Foundation announced a screening and public awareness campaign to test for fatty liver disease over the next five years.
Read More